YouTube - Volunteering for Clinical Trials
Links shared publicly online about this topic.
- 1,085total visits
YouTube - Volunteering for Clinical Trials
View full resource at youtube.com
Tags: Clinical Trial
Most Recently Shared on June 18, 2010 at 3:37 pm By:
I uploaded a YouTube video -- 60sec spot.wmv http://youtu.be/jDd7RXjPRWM?a
Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases
hindawi.com — “Cardiovascular diseases are one of the major causes of deaths in adults in the western world. Elevated levels of certain blood lipids have been reported to be the principal cause of cardiovascular disease and other disabilities in developed countries. Several animal and clinical trials have shown a positive association between cholesterol levels and the risks of coronary heart disease. Current dietary strategies for the prevention of cardiovascular disease advocate adherence to low-fat/low-satur” View full resource at hindawi.com
Most Recently Shared on May 3, 2012 at 6:29 pm By:
Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases: Cardiovascular diseases are... http://t.co/WvFFZulO
Analysis Finds Clinical Trials Often Small, of Poor Quality
consumer.healthday.com — “Analysis Finds Clinical Trials Often Small, of Poor Quality” View full resource at consumer.healthday.com
Most Recently Shared on May 1, 2012 at 10:36 pm By:
Barbara Bronson Gray, RN, MN Nurse and Health Marketing
Analysis finds clinical trials, used to prove #drugs are safe & effective, don't involve enough people, + other issues. http://t.co/9xJvmrCW
Enrollment complete in Zalicus Synavive Phase 2b clinical trial for rheumatoid arthritis
news-medical.net — “Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced it has completed enrollment with 292 patients enrolled in the SYNERGY trial, a Phase 2b clinical trial designed to evaluate the safety and efficacy of Synavive, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in patients with rheumatoid arthritis (RA).” View full resource at news-medical.net
Most Recently Shared on April 30, 2012 at 6:18 pm By:
Arthritis News: Enrollment complete in Zalicus Synavive Phase 2b clinical trial for rheumatoid arthritis: Zalicu... http://t.co/RMkrrbrn
Actelion breathes easy on best case new drug data | Reuters
reuters.com — “ZURICH/LONDON (Reuters) - A new lung and heart drug from Actelion beat expectations in a key clinical trial, giving a much-needed boost to its pipeline and providing Europe's leading biotech company with” View full resource at reuters.com
Most Recently Shared on April 30, 2012 at 8:44 am By:
Ben Hirschler Health Communicator
#Actelion breathes easy on "best case" new drug data - stock up 18% http://t.co/Y0kr5VdG via @reuters
Actelion Lung Drug Meets Main Goal in Pivotal Study - Bloomberg
bloomberg.com — “Actelion Ltd.’s experimental lung drug macitentan met the main goal of a late-stage clinical trial, giving the company a possible successor to a treatment that accounts for 89 percent of sales. The shares rose the most since the company went public in 2000.” View full resource at bloomberg.com
Most Recently Shared on April 30, 2012 at 6:12 am By:
Actelion Lung Drug Meets Main Goal in Pivotal Patient Study: Actelion Ltd. (ATLN) ’s experimental lung drug maci... http://t.co/YcbqEfeX
The Clinical Trials Guru
theclinicaltrialsguru.com — “The Clinical Trials Guru” View full resource at theclinicaltrialsguru.com
Most Recently Shared on April 25, 2012 at 3:42 pm By:
Miriam E. Tucker Patient Expert
RT @TheRealDanSfera: #Diabetes and Clinical Trials, Our Interview With Ryan Luce http://t.co/PsWZcoeh @corengi
How the FDA Stifles New Cures, Part I: The Rising Cost of Clinical Trials - Forbes
forbes.com — “Today, the Manhattan Institute released a study I authored, entitled “Stifling New Cures: The True Cost of Lengthy Clinical Drug Trials.” (You can read the full report here.) The paper discusses how outdated FDA policies are making drug development too expensive and too risky. In this excerpt, I describe the factors that are driving up the cost of clinical trials.” View full resource at forbes.com
Most Recently Shared on April 25, 2012 at 12:02 am By:
Matthew Bowdish MD Physician, Doctor, Internist, and Allergist
How the FDA Stifles New Cures, Part I: The Rising Cost of Clinical Trials by @aviksaroy http://t.co/EfMDpHmv
Bioethics Bootcamp: Conflicts of Interest: Research and Clinical Ethics - YouTube
youtube.com — “Conflicts of Interest: Research and Clinical Ethics Friday, March 30, 2012 City University of New York Graduate School of Journalism Doug Levy, Executive Dir...” View full resource at youtube.com
Most Recently Shared on April 24, 2012 at 6:12 pm By:
Ivan Oransky Doctor and Health Communicator
Bioethics Bootcamp reporting on conflicts of interest panel video featuring me @charlesornstein @nydoug http://t.co/dPrMwOue
Corengi is changing the way patients discover clinical trials
imedicalapps.com — “Corengi, the AdSense of clinical trials, is using embeddable widgets on third-party website to help patients find and better understand clinical trials.” View full resource at imedicalapps.com
Most Recently Shared on April 24, 2012 at 1:29 pm By:
Corengi is changing the way patients discover clinical trials http://t.co/3norWqHX
Services Match Patients With Clinical Trials - WSJ.com
online.wsj.com — “A growing number of patient-advocacy groups are playing matchmaker, linking patients to clinical trials.” View full resource at online.wsj.com
Most Recently Shared on April 24, 2012 at 10:21 am By:
Seth Bilazarian Doctor, Internist, Cardiologist, Physician, and Active Health Library
@WSJ Matching Patients With Clinical Trials http://t.co/xRSlBm2l > pts want easier access to info, advocacy groups deliver
Naproxen lessens pegfilgrastim-induced bone pain - The Doctor's Channel
thedoctorschannel.com — “NEW YORK (Reuters Health) – Cancer patients given pegfilgrastim experience less bone pain if they take naproxen 500 mg twice daily for about a week, according to the results of a randomized placebo-controlled trial reported in the Journal of Clinical Oncology online April...” View full resource at thedoctorschannel.com
Most Recently Shared on April 23, 2012 at 10:21 pm By:
Dr Michael Banks - The Doctor's Channel Health Site
How have your patients responded to the use of naproxen? - From Reuters Health/TDC http://t.co/0TVzztOX #cancer #pain #health
NextBio Announces NextBio Clinical, Integrates Patient Genomic Data | Biomarker Commons
biomarkercommons.org — “NextBio announced today NextBio Clinical, an extension of the company’s existing life sciences platform to translational medicine applications such as biomarker discovery and clinical trial optimization. NextBio Clinical enables the application of clinical information earlier in the discovery process to enhance research and development.” View full resource at biomarkercommons.org
Most Recently Shared on April 23, 2012 at 2:43 pm By:
Study: Use of drug following first sign of possible MS reduces likelihood of progression to MS
eurekalert.org — “People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21-28, 2012.” View full resource at eurekalert.org
Most Recently Shared on April 20, 2012 at 7:17 am By:
Study: Use of drug following first sign of possible MS reduces likelihood of progression to MS: ( American Acade... http://t.co/DJO0pAcf
Revised View Enhances Provenge OS Data
onclive.com — “A further analysis of clinical trial data for sipuleucel-T suggests that it may have delivered a greater OS benefit than previously described.” View full resource at onclive.com
Most Recently Shared on April 19, 2012 at 9:28 pm By:
Revised View Enhances Provenge OS Data http://t.co/0tCNQgLP #prostatecancer
Sanofi and Michael J. Fox Foundation Collaborate on Potential New Treatment for Parkinson's... -- PARIS, April 19, 2012 /PRNewswire/ --
prnewswire.com — “Sanofi and Michael J. Fox Foundation Collaborate on Potential New Treatment for Parkinson's Disease. - Fox Foundation to sponsor a clinical trial to study Sanofi compound -.” View full resource at prnewswire.com
Most Recently Shared on April 19, 2012 at 1:15 pm By:
Scott Strumello Patient Expert
PR: Sanofi and Michael J. Fox Foundation Collaborate on Potential New Treatment for Parkinson's http://t.co/VR1kr3k3 via @PRNewswire
Advertisement
